Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 3Completed 3Terminated 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Lymphoid 3Gastrointestinal 3Thoracic 2Head & Neck 2Dermatologic 2Other hematologic neoplasm 1Myeloid 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Head and Neck Neoplasms 276Squamous Cell Carcinoma of Head and Neck 241Carcinoma, Non-Small-Cell Lung 86Melanoma 68Neoplasms 61Colorectal Neoplasms 52Neoplasm Metastasis 48Carcinoma, Squamous Cell 48Thyroid Neoplasms 47Breast Neoplasms 41Carcinoma, Renal Cell 36Lung Neoplasms 34Ovarian Neoplasms 33Oropharyngeal Neoplasms 30Stomach Neoplasms 29Mouth Neoplasms 29Nasopharyngeal Carcinoma 28Triple Negative Breast Neoplasms 26Uterine Cervical Neoplasms 25Sarcoma 25Laryngeal Neoplasms 24Pancreatic Neoplasms 23Esophageal Neoplasms 23Salivary Gland Neoplasms 21Urinary Bladder Neoplasms 20Recurrence 19Nasopharyngeal Neoplasms 18Small Cell Lung Carcinoma 17Carcinoma, Transitional Cell 17Prostatic Neoplasms 16

Interventions

SF 1126 1Cetuximab 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hereditary Sensory and Autonomic Neuropathies × Head & Neck × Clear all
NCT01602315 2020-12-29

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Novartis

Phase 1/2 Terminated
179 enrolled 38 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hereditary Sensory and Autonomic Neuropathies

NCT02644122 2018-07-11

SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

University of California, San Diego

Phase 2 Terminated
1 enrolled 6 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡